Drug resistance of Staphylococcus heamolytieus causing bloodstream infections

ZHAO Yan,YUAN Yi-qun,YE Qin,LUO Xiao-hua,LI Gang,ZHOU Dan-qiu
2013-01-01
Abstract:OBJECTIVE To determine the distribution and drug resistance of Staphylococcus heamolytieus causing bloodstream infections so as to guide the clinical medication.METHODS From 2009 to 2010,a retrospective survey was conducted on the clinical data and microbial data of the patients with bloodstream infections caused by the S.haemolyticus.RESULTS Totally 50 strains of non-repetitive S.haemolyticus were isolated from Jan 2009 to Dec 2010,26% of which were isolated from the neonatal department,followed by the emergency department and ICU.The drug resistance rate of the S.haemolyticus to penicillin was the highest,with 86.7% in 2009,90% in 2010.The detection rate of methicillin-resistant S.haemolyticus(MRSH)was 60% in 2009,75% in 2010,while the vancomycin-,linezolid-,or teicoplanin-resistant strains were not found.CONCLUSION S.haemolyticusis the predominant species of pathogen causing the bloodstream infections and is highly drug resistant.
What problem does this paper attempt to address?